Literature DB >> 14600422

Tuning of innate immunity and polarized responses by decoy receptors.

Alberto Mantovani1, Raffaella Bonecchi, Fernando O Martinez, Emanuela Galliera, Patrick Perrier, Paola Allavena, Massimo Locati.   

Abstract

After the identification of the interleukin (IL)-1 type II receptor as the prototype, decoy receptors have been identified for a number of members of the IL-1/IL-18, TNF, IL-10 and IL-13 receptor families. Moreover, the silent receptor D6 is a promiscuous decoy and scavenger receptor of inflammatory chemokines. The IL-1 decoy receptor is regulated by pro- and anti-inflammatory signals and its levels may serve as a readout of the activation of anti-inflammatory pathways, for instance by glucocorticoid hormones. Decoy receptors represent a strategy to tune inflammatory and polarized adaptive responses. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14600422     DOI: 10.1159/000073711

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  12 in total

1.  IL-1β is overexpressed and aberrantly regulated in corticosteroid nonresponders with autoimmune inner ear disease.

Authors:  Shresh Pathak; Elliot Goldofsky; Esther X Vivas; Vincent R Bonagura; Andrea Vambutas
Journal:  J Immunol       Date:  2011-01-03       Impact factor: 5.422

2.  Early alterations in cytokine expression in adult compared to developing lung in mice after radiation exposure.

Authors:  Carl J Johnston; Eric Hernady; Christina Reed; Sally W Thurston; Jacob N Finkelstein; Jacqueline P Williams
Journal:  Radiat Res       Date:  2010-04       Impact factor: 2.841

Review 3.  The attraction of chemokines as a target for specific anti-inflammatory therapy.

Authors:  James E Pease; Timothy J Williams
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

4.  The FGFRL1 receptor is shed from cell membranes, binds fibroblast growth factors (FGFs), and antagonizes FGF signaling in Xenopus embryos.

Authors:  Florian Steinberg; Lei Zhuang; Michael Beyeler; Roland E Kälin; Primus E Mullis; André W Brändli; Beat Trueb
Journal:  J Biol Chem       Date:  2009-11-17       Impact factor: 5.157

5.  The local and systemic inflammatory transcriptome after acute kidney injury.

Authors:  Dmitry N Grigoryev; Manchang Liu; Heitham T Hassoun; Chris Cheadle; Kathleen C Barnes; Hamid Rabb
Journal:  J Am Soc Nephrol       Date:  2008-01-30       Impact factor: 10.121

Review 6.  Role of IRE1α/XBP-1 in Cystic Fibrosis Airway Inflammation.

Authors:  Carla M P Ribeiro; Bob A Lubamba
Journal:  Int J Mol Sci       Date:  2017-01-09       Impact factor: 5.923

7.  Myocardial infarction causes inflammation and leukocyte recruitment at remote sites in the myocardium and in the renal glomerulus.

Authors:  Neil Ruparelia; Janet E Digby; Andrew Jefferson; Debra J Medway; Stefan Neubauer; Craig A Lygate; Robin P Choudhury
Journal:  Inflamm Res       Date:  2013-03-08       Impact factor: 4.575

8.  The human complement fragment receptor, C5L2, is a recycling decoy receptor.

Authors:  Anne-Marie Scola; Kay-Ole Johswich; B Paul Morgan; Andreas Klos; Peter N Monk
Journal:  Mol Immunol       Date:  2008-12-18       Impact factor: 4.407

9.  Alternate splicing of interleukin-1 receptor type II (IL1R2) in vitro correlates with clinical glucocorticoid responsiveness in patients with AIED.

Authors:  Andrea Vambutas; James DeVoti; Elliot Goldofsky; Michael Gordon; Martin Lesser; Vincent Bonagura
Journal:  PLoS One       Date:  2009-04-29       Impact factor: 3.240

10.  Cyclophosphamide alters the gene expression profile in patients treated with high doses prior to stem cell transplantation.

Authors:  Ibrahim El-Serafi; Manuchehr Abedi-Valugerdi; Zuzana Potácová; Parvaneh Afsharian; Jonas Mattsson; Ali Moshfegh; Moustapha Hassan
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.